DE3907114C2 - - Google Patents
Info
- Publication number
- DE3907114C2 DE3907114C2 DE3907114A DE3907114A DE3907114C2 DE 3907114 C2 DE3907114 C2 DE 3907114C2 DE 3907114 A DE3907114 A DE 3907114A DE 3907114 A DE3907114 A DE 3907114A DE 3907114 C2 DE3907114 C2 DE 3907114C2
- Authority
- DE
- Germany
- Prior art keywords
- temperature
- induction
- incubation
- cytokines
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004127 Cytokines Human genes 0.000 claims description 20
- 108090000695 Cytokines Proteins 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- 230000006698 induction Effects 0.000 claims description 13
- 238000011534 incubation Methods 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 230000015572 biosynthetic process Effects 0.000 claims description 9
- 238000003786 synthesis reaction Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 7
- 210000000265 leukocyte Anatomy 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 102000000412 Annexin Human genes 0.000 description 2
- 108050008874 Annexin Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 2
- HIYAVKIYRIFSCZ-CVXKHCKVSA-N Calcimycin Chemical compound CC([C@H]1OC2([C@@H](C[C@H]1C)C)O[C@H]([C@H](CC2)C)CC=1OC2=CC=C(C(=C2N=1)C(O)=O)NC)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-CVXKHCKVSA-N 0.000 description 1
- 102000003712 Complement factor B Human genes 0.000 description 1
- 108090000056 Complement factor B Proteins 0.000 description 1
- 108010062580 Concanavalin A Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- HIYAVKIYRIFSCZ-UHFFFAOYSA-N calcium ionophore A23187 Natural products N=1C2=C(C(O)=O)C(NC)=CC=C2OC=1CC(C(CC1)C)OC1(C(CC1C)C)OC1C(C)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-UHFFFAOYSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000002555 ionophore Substances 0.000 description 1
- 230000000236 ionophoric effect Effects 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 150000004633 phorbol derivatives Chemical class 0.000 description 1
- 239000002644 phorbol ester Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU881049A HU202594B (en) | 1988-03-04 | 1988-03-04 | Process for increasing yield of leucoquines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3907114A1 DE3907114A1 (de) | 1989-09-14 |
| DE3907114C2 true DE3907114C2 (it) | 1991-12-19 |
Family
ID=10952631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE3907114A Granted DE3907114A1 (de) | 1988-03-04 | 1989-03-06 | Verfahren zur herstellung von cytokinen |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPH0724595B2 (it) |
| CN (1) | CN1036794A (it) |
| AT (1) | AT392800B (it) |
| DE (1) | DE3907114A1 (it) |
| HU (1) | HU202594B (it) |
| IT (1) | IT1229193B (it) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2906160A1 (de) * | 1979-02-17 | 1980-09-04 | Thomae Gmbh Dr K | Verbessertes verfahren zur herstellung von humaninterferon |
| US4357422A (en) * | 1980-08-14 | 1982-11-02 | Massachusetts Institute Of Technology | Method of enhancing interferon production |
| JPS57105195A (en) * | 1980-10-24 | 1982-06-30 | Nat Res Dev | Production of interferon |
| JPS6296083A (ja) * | 1985-10-21 | 1987-05-02 | Toray Ind Inc | 動物細胞の培養方法 |
-
1988
- 1988-03-04 HU HU881049A patent/HU202594B/hu not_active IP Right Cessation
-
1989
- 1989-03-03 IT IT8919632A patent/IT1229193B/it active
- 1989-03-03 JP JP1050209A patent/JPH0724595B2/ja not_active Expired - Lifetime
- 1989-03-03 AT AT481/89A patent/AT392800B/de not_active IP Right Cessation
- 1989-03-03 CN CN89102021.7A patent/CN1036794A/zh active Pending
- 1989-03-06 DE DE3907114A patent/DE3907114A1/de active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IT1229193B (it) | 1991-07-25 |
| ATA48189A (de) | 1990-11-15 |
| IT8919632A0 (it) | 1989-03-03 |
| HUT50218A (en) | 1989-12-28 |
| JPH01281095A (ja) | 1989-11-13 |
| AT392800B (de) | 1991-06-10 |
| JPH0724595B2 (ja) | 1995-03-22 |
| CN1036794A (zh) | 1989-11-01 |
| HU202594B (en) | 1991-03-28 |
| DE3907114A1 (de) | 1989-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69029657T2 (de) | Menschliches cytokin, interleukin-9 | |
| DE69020573T2 (de) | Verfahren zur wachstumshemmung von stammzellen. | |
| DE3043981C2 (it) | ||
| DE2927841C2 (de) | Verfahren zur Herstellung einer biologischen Zusammensetzung zur Verwendung als Blutserum-Bezugszusammensetzung für diagnostische Analysezwecke | |
| DE3751922T2 (de) | Herstellung und Verwendung von IL-6 | |
| DE69127296T2 (de) | Änderung der haarwuchsgeschwindigkeit und des -charakters | |
| DE3689246T2 (de) | Physiologisch aktives Polypeptid BUF-3. | |
| EP0152944A3 (de) | Verwendung von Adenosin-Derivaten als Antiallergica und Arzneimittel, die diese enthalten | |
| EP0456200A1 (de) | Muteine des Granulozyten-Kolonie-stimulierenden Faktors (G-CSF) | |
| DE3704389C2 (it) | ||
| DE3639725C2 (de) | Human-Mangansuperoxiddismutase-cDNA, ihre Expression in Bakterien und Verfahren zur Reindarstellung enzymatischer aktiver Human-Mangansuperoxiddismutase sowie Arzneimittel | |
| DE3829524A1 (de) | Verwendung von transglutaminasen als immunsuppressiva | |
| DE3434122C2 (it) | ||
| DE3711054A1 (de) | Biophysikalisch derivatisiertes hefepraeparat, verfahren zu dessen herstellung und dieses hefepraeparat enthaltende futtermittel und pflanzenwuchsstoffe | |
| DE3319714C2 (it) | ||
| DE3907114C2 (it) | ||
| DE3325131C2 (it) | ||
| EP0537427B1 (de) | Verfahren zur Herstellung von Huminaten | |
| EP0286927A3 (de) | Neue Pyrrolidin-2-(1,3-dicarbonyl)-Derivate, Verfahren zu ihrer Herstellung, sie enthaltende Mittel sowie deren Verwendung | |
| Moment | The Ponce de Leon trail today | |
| DE182106T1 (de) | Verfahren und zusammensetzungen zur behandlung von feuerbrand. | |
| EP0146107A2 (de) | Verfahren zur nacheinanderfolgenden Herstellung von humanem Leukozyteninterferon und humanem Gamma-Interferon | |
| DE3249215C2 (de) | Verfahren zur herstellung von humanem gamma-interferon. | |
| EP0041189A1 (de) | Verfahren zur Herstellung von Interferon II und stimulierte Klone zur Durchführung des Verfahrens | |
| DE4244437A1 (de) | Verfahren zur Gewinnung körpereigener Zytokine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |